Associate Professor of Radiation Oncology, University Tex Houston
Radiation Oncology
Dr. Anuja Jhingran, MD
|
|
Give Review
Anuja Jhingran is an expert in the field of Radiation Oncology. She studied medicine at Baylor College of Medicine. She has 4 awards "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Whos Who in Medicine and Healthcare". Dr. Anuja Jhingran is a published MD. She published 81 publications, including: 'Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Management of nodal recurrences of endometrial Cancer with IMRT.
- Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic Cancer: A report of 2 cases.
- Isolated Port-Site Metastases After Minimally Invasive Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy.
- Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical Cancer.
- Survival outcomes for patients with stage IVB Vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system?
- Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical Cancer.
- Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer.
- ACR Appropriateness Criteria® Advanced Stage Endometrial Cancer.
- Patient Preferences for Side Effects Associated With Cervical Cancer Treatment.
- Radiation therapy oncology group gynecologic oncology working group: comprehensive results.
- Response to an exercise intervention after endometrial Cancer: Differences between obese and non-obese survivors.
- Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic Cancer.
- Acr appropriateness Criteria management of vaginal Cancer.
- Prospective study of symptom assessment among patients with cervical Cancer during concurrent chemoradiotherapy with weekly Cisplatin or every-3-week Cisplatin and 5-F...
- ACR Appropriateness Criteria® Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva.
- Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): A phase III clinical trial comparing surgical to radiologic staging in patients with stages IB2-IVA...
- Involved-field radiation therapy for locoregionally recurrent ovarian Cancer.
- Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer.
- Intensity modulated radiotherapy in gynecologic Cancers: Hope, hype or hyperbole?
- Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix.
- A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.
- Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer.
- Anatomic Location of PET-Positive Aortocaval Nodes in Patients with Locally Advanced Cervical Cancer: Implications for Surgical Staging.
- A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0...
- Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix Cancer scenarios.
- Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical Cancer.
- American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: Low-dose-rate and pulsed-dose-rate brachytherapy.
- Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin and Amifostine for Cervical Cancer With Positive Para-Aortic or High Common Iliac Ly...
- ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial Cancer of the uterus.
- PET/CT in a Patient With Adenoma Malignum of the Uterine Cervix.
- Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical Cancer1: a prospective correlation of surgical findings with positron emission to...
- ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.
- Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy.
- Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical Cancer.
- Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix Cancer.
- Expression of nuclear transcription factor kappa B in locally advanced human cervical Cancer treated with definitive chemoradiation.
- Pelvic fractures after radiotherapy for cervical Cancer: implications for survivors.
- Concurrent chemoradiation in the routine management of patients with cervical Cancer: does marital status matter?
- Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
- Patterns of regional recurrence after definitive radiotherapy for cervical Cancer.
- Changes in gene expression predicting local control in cervical Cancer: results from Radiation Therapy Oncology Group 0128.
- Predictive value of a proposed subclassification of stages I and II cervical Cancer based on clinical tumor diameter.
- Evaluation of intervention to prevent hypomagnesemia in cervical Cancer patients receiving combination cisplatin and radiation treatment.
- Physical activity and obesity in endometrial Cancer survivors: associations with pain, fatigue, and physical functioning.
- Radical hysterectomy in obese and morbidly obese women with cervical Cancer.
- Cervix regression and motion during the course of external beam chemoradiation for cervical Cancer.
- Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.
- Lymphatic mapping and sentinel lymph node detection in women with vaginal Cancer.
- Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical Cancer.
- Eleven years: the long and winding road.
- Comparison of treatment tolerance and outcomes in patients with cervical Cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with sta...
- Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical Cancer with positive para-aortic or high common iliac lymp...
- Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure.
- Retroperitoneal lymph node resection in patients with cervical Cancer.
- Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies.
- Advanced cervical Cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy.
- Uterine Cancers.
- Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study.
- Quality of life and sexual functioning in cervical Cancer survivors.
- Clinical investigation: regional nodal failure patterns in breast Cancer patients treated with mastectomy without radiotherapy.
- A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cerv...
- Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ.
- Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
- Definitive radiation therapy for squamous cell carcinoma of the vagina.
- Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiothe...
- Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.
- Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
- Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
- Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
- Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
- Innovations in the treatment of invasive cervical Cancer.
- Groin recurrence in patients with Vulvar cancer with negative nodes on superficial inguinal lymphadenectomy.
- A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molec...
- The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva.
- Is team management appropriate for a patient receiving coronary brachytherapy?
- Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy.
- Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma.
- Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast Cancer response to chemotherapy.
- Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience.
- Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical Cancer.
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Whos Who in Medicine and Healthcare
Education
-
Baylor College of Medicine -
Texas Tech University Health Sciences Center School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1437244522 | |
| NPPES Provider LastName | JHINGRAN | |
| NPPES Provider FirstName | ANUJA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 98.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437244522 |
| Last Name Of The Provider | JHINGRAN |
| First Name Of The Provider | ANUJA |
| View All |
Similar Doctors
|
|
Dr. Sean E. McGuire, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ritsuko Komaki, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Valerie K. Reed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Grosshans, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Zhongxing Liao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry Mok, MD |
|
Dr. Larry S. Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clifton D. Fuller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randa Tao, MD |
|
|
Dr. Corey W. Speers, MD
This Doctor is OpenDoctor Recommended.
|